Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Clinical and Experimental Rheumatology|December 19, 2024
Abatacept use for 24 weeks has a limited effect on salivary gland inflammation in Sjögren's disease patientsUzma Nakshbandi, Silvia C Liefers, Suzanne Arends, et al.
The Journal of Rheumatology|June 3, 2011
Serum MMP-3 level as a biomarker for monitoring and predicting response to etanercept treatment in ankylosing spondylitisSuzanne Arends, Eveline van der Veer, Henk Groen, et al.
Rheumatology (Oxford, England)|July 9, 2018
Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sjögren's syndromeGwenny M Verstappen, Rada V Moerman, Jolien F van Nimwegen, et al.
Rheumatology (Oxford, England)|June 29, 2020
Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines)Johanna Westra, Elisabeth Brouwer, Elisabeth Raveling-Eelsing, et al.
Clinical and Experimental Rheumatology|May 11, 2019
Presence of intraepithelial B-lymphocytes is associated with the formation of lymphoepithelial lesions in salivary glands of primary Sjögren's syndrome patientsMartha S van Ginkel, Erlin A Haacke, Hendrika Bootsma, et al.
Clinical and Experimental Rheumatology|November 28, 2022
Patient Acceptable Symptom State (PASS) in patients with primary Sjögren's syndrome in daily clinical practiceLiseth de Wolff, Arjan Vissink, Jolien F van Nimwegen, et al.
The Journal of Rheumatology|January 3, 2017
B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren SyndromeGwenny M Verstappen, Frans G M Kroese, Petra M Meiners, et al.
Pageof 14